Global tissue engineering market is expected to reach USD 11.53 billion
by 2022, according to a new report by Grand View Research, Inc. The demand for
tissue engineering is expected to upsurge owing to the shift of focus from stem
cell therapies to immunocelluar therapies. Moreover, companies such as
Caladrius and Celyad changed their names from Cardio3 Bio NeoStem respectively
to reflect their focus on immunotherapies.
The market is also experiencing industry-academia collaboration to make
the commercialization of viable cell therapies possible. In July 2015, Fate
Therapeutics, Inc. collaborated with theUniversity of Minnesota to research on
Natural Killer (NK) therapeutics, which can detectand kill the malignant cells.
The research is expected to accelerate with the use of programmed therapeutics
by Fate Therapeutics.
With the technological advancements, researchers are working upon
custom-made body parts with the aid of biomaterials and bio 3D printing. The
demand for orthopedic implants is continuously growing; however, there is a gap
between the demand and supply. To address such issues, researchers are
experimenting with ways to find out alternatives, which use in-vitro testing
and humane substitutes.
Investigators are working on ways to develop 3D printed organs, which can
offer low-cost implantation. This step can revolutionize the 3D printing
industry, but many hurdles such as donor availability, technologically-advanced
3D printers, and financial barriers have to be overcome. For instance, the cost
of 3D printing ranges from USD 100 for tracheal split to USD 40,000 for nose
bio-printing. Thus, there is a need for scientists and researchers to work on
this multidisciplinary aspect of bio-printing.
In depth research report
on Tissue Engineering Market
Further key findings from
the report suggest:
·
Orthopedics dominated the application segment in 2014 owing to the
continuous launch of new products and research funding. In February 2016,
Geistlich Pharma launched a range of bone harvesting instrument for the
efficient collection of autogenous bone. Implant of only autogenous bone causes
resorption and volume depletion. With the use of Geistlich Bio-Oss-pioneered
technology, the volume as well as properties of bone is restored.
·
North America was the largest regional market with a revenue share
estimated at over 50% owing to the various mergers and acquisitions along with
huge funds available for research. In March 2016, Zimmer Bimet acquired Ortho
Transmission for its pioneered technology, which could restore limb amputee
patients.
·
By acquiring the skeletal implant technology, Zimmer can efficiently work
on its current project received by the U.S. Department of Defense to develop
external prosthetic limbs. Moreover, in February 2016, Canadian scientists from
the University of Toronto’s dentistry pioneered a 3D printed method for
absorbable bone-implant.
·
Europe was the second largest market in 2014, due to the amount of
research and the funding received by the research universities. For instance,
in June 2014, the European Union funded the VascuBone project to offer an
alternative to bone grafts. The University Hospital of Wurzburg developed a
toolbox to bring together the solutions required to offer ideal therapy to
patients.
·
Countries in Europe are also expanding their research knowledge by
partnering with other countries’ research firms. For instance, in March 2013,
Johannes Gutenberg University Mainz and Chinese Academy of Sciences formed the
Chinese-German Joint Center for Bio-Inspired Materials. The scientists will
work on using marine animals for osteoporosis medication.
·
Asia Pacific is the fastest growing regional segment on the account of increasing
interest of foreign players to establish their facilities in economically
developed countries such as India and Japan. In August 2013, the Japan Health
Ministry approved the clinical trial of the developing induced pluriponent stem
(iPS) cells for blindness. The cells are morphed into retinal cells and then
given to six patients with macular degeneration (AMD).
·
India is in an ascent stage of research and trying to develop in the
tissue engineering area. In February 2016, India Biotechnology Event was held,
where experts blamed the snail pace of development to the tedious and long
approval process. The suggestion was to adopt Japan’s new executed law, where
the sponsor has to demonstrate only the safety and efficacy studies of the
device.
·
Key players of this market includeMedtronic, Inc., Zimmer Biomet,
Acelity, Acell, Inc., Athersys, Inc., Organogenesis, Inc., Stryker Corporation,
Tissue Regenix Group Plc, RTI surgical, Inc., and ReproCell, Inc.
·
Industry contributors are establishing their market presence by acquiring
other companies or by launching new products in the market. In November 2015,
ReproCell, Inc. acquired Biopta to leverage on Bipota’s clinical network in the
U.S and the UK. Biopta has worked on around 500 new medicines and has partnerships
with Scottish Enterprise and the NHS. Moreover, in February 2016, RTI Surgical,
Inc. received exclusive licensing rights by RTI Surgical, Inc. Through this,
RTI can access the OPM’s OsteoFab technology for spinal procedures.
Grand View Research has segmented the global tissue engineering market on
the basis of application andregions:
Tissue Engineering
Application Outlook (Revenue, USD Million, 2012 - 2022)
·
Cord Blood & Cell Banking
·
Cancer
·
GI & Gynecology
·
Dental
·
Skin/Integumentary
·
Urology
·
Orthopedics, musculoskeletal and spine
·
Neurology
·
Cardiology & Vascular
Tissue Engineering
Regional Outlook (Revenue, USD Million, 2012 - 2022)
·
North America
·
U.S.
·
Canada
·
Europe
·
UK
·
France
·
Germany
·
Asia Pacific
·
India
·
China
·
Japan
·
Latin America
·
Brazil
·
Mexico
·
MEA
·
South Africa
Browse more research
reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment